While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

Preserving what's left of a python after its caught and killed requires a great deal of time, skill and patience.

We caught up with two professional python hunters and asked them what are the "essentials" that help them be successful in ...

Buy: Anthropic exposure via its likely IPO/secondary path (e.g., IPO allocation or liquid proxy like AI-safety/compute beneficiaries). Rationale: Anthropic is pushing “slow/pause” policy while still ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. Join the Tom's Guide ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...

If Python developers have one consistent gripe about their beloved language, it tends to be this: Why is it so hard to take a Python program and deploy it as a standalone artifact, the way C, C++, ...

I was 11 years old when I learned that I talk funny. A new teacher who didn’t share my Boston accent was surprised by the way I said “kindergarten.” She mockingly repeated my pronunciation back to me: ...

Has anyone ever poked fun at the way you talk, how you pronounce a word or phrase? For Philadelphians, it might be “wooder” “caw-fee” “bee-yoo-dee-full” or “jeet?” But all of us have some kind of ...

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to supercharge its AI-driven drug discovery platform through an expanded ...